GLAXO
GLAXOSMITHKLINE PHARMA LT

2332.0 +67.71 (+2.9%)

Don't cash in on GLAXO now, it outperformed most of it's peers

19 Jun, 20265 min read

GLAXOSMITHKLINE PHARMA LT outperformed the broader market on Friday. It increased by +2.9% to close at 2332.0. On a day when the overall market breadth was 35%, it closed higher than 70% of the market. In comparison, the benchmark NIFTY-50 index closed today at -0.0064%.

Want to improve your Portfolio's performance?
Spotalpha's Portfolio optimizer is all you need to improve your returns and reduce your risk.
Optimize Portfolio NOW
Read analysis
Following
Symbol Price {{retType}} | Tr.
{{detail.symbol}} {{detail.close}} {{detail.priceChange}}  {{detail.pctChange}}%  {{detail.name}} {{detail.trend}}